Ixiaro Interactions
There are 298 drugs known to interact with Ixiaro (japanese enceph vacc sa14-14-2, inactivated), along with 1 disease interaction. Of the total drug interactions, 1 is major, 295 are moderate, and 2 are minor.
- View all 298 medications that may interact with Ixiaro
- View Ixiaro disease interactions (1)
Most frequently checked interactions
View interaction reports for Ixiaro (japanese enceph vacc sa14-14-2, inactivated) and the medicines listed below.
- amlodipine
- amphetamine
- aspirin
- atovaquone / proguanil
- azithromycin
- benztropine
- bismuth subsalicylate
- Brilinta (ticagrelor)
- BuSpar (buspirone)
- buspirone
- cephalexin
- chloroquine
- Cialis (tadalafil)
- Cipro (ciprofloxacin)
- clonidine
- Effexor (venlafaxine)
- famotidine
- ibuprofen
- Lexapro (escitalopram)
- Lotensin (benazepril)
- metaxalone
- methenamine
- methocarbamol
- midodrine
- naproxen
- nitrofurantoin
- omeprazole
- quetiapine
- RabAvert (rabies vaccine, purified chick embryo cell)
- Seroquel (quetiapine)
Ixiaro disease interactions
There is 1 disease interaction with Ixiaro (japanese enceph vacc sa14-14-2, inactivated) which include:
Report options
QR code containing a link to this page
More about Ixiaro (japanese enceph vacc sa14-14-2, inactivated)
- Ixiaro consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: viral vaccines
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.